Overview (04 Nov 2026)
Cohance Lifesciences Ltd
COHANCE
INE03QK01018
Pharmaceuticals
10.05
Prev. Close
Previous Close
440.15
Current Close
450.2
Current High
452
Current Low
436.4
52 Week High
748.95
52 Week Low
267.85
Resistance 1
456.00
Resistance 2
461.80
Support 1
440.40
Support 2
424.80
Std Deviation
2.41%
DMA 200
409.20
DMA 50
452.18
DMA 20
454.36
Fundamentals and Ratios
Standalone
Trailing EPS
5.98
Forwad EPS
2.01
Trailing P/E
75.28
Forward P/E
223.61
PEG Ratio
Mkt. Cap (Cr)
Market Cap (Cr)
17223.17
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26567.55481.58497.79483.582030.5
Other Income12.25-0.796.1226.3013.1044.73
Total Income434.51566.76487.70524.09496.682075.23
Interest6.745.175.255.246.8022.46
Expenditure-477.38-493.81-417.41-403.37-417.54-1732.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-37.66-33.36-31.20-31.36-133.58
PBT-42.8756.4465.43120.7271.04313.63
Tax-2.32-21.88-18.14-26.43-18.47-84.92
Equity38.2638.260.000.0038.2638.26
OPM-9.879.9613.5924.2514.3015.11
Net Profit-45.1934.5647.2994.2952.57228.71
NPM-10.46.19.8218.9410.5811.02
EPS-0.630.91.242.461.385.98
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26619.12544.55555.57549.312268.55
Other Income12.25-1.846.1615.6014.1734.09
Total Income434.51617.28550.71571.17563.482302.64
Interest6.749.190.008.7610.1837.24
Expenditure-477.38-580.86-505.25-487.40-492.62-2066.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-51.230.00-44.02-45.14-187.33
PBT-42.8719.9140.6083.7762.76207.04
Tax-2.32-11.60-11.58-17.38-16.36-56.92
Equity38.2638.260.000.0038.2638.26
OPM-9.873.237.3714.6711.148.99
Net Profit-45.198.3129.0266.3946.4150.12
NPM-10.41.355.2711.628.236.52
EPS-0.630.5101.941.284.69
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings